Results 1 to 10 of about 267,025 (294)
Global epidemiology of systemic lupus erythematosus
Nature Reviews Rheumatology, 2021 Megan R W Barber +2 more
exaly +2 more sources
Systemic Lupus Erythematosus [PDF]
Clinical and Developmental Immunology, 2012 Systemic lupus erythematosus (SLE) is the prototypical autoimmune disease, associated with autoantibody production and evidence for immune complex deposition among the many aspects of its pathophysiology. SLE occurs most commonly in women during their reproductive years.
Anne Davidson +3 more
+12 more sources
Autoimmunity and organ damage in systemic lupus erythematosus
Nature Immunology, 2020 George C Tsokos
exaly +2 more sources
Systemic lupus erythematosus [PDF]
Orphanet Journal of Rare Diseases, 2006 Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmune in origin and is characterized by the presence of autoantibodies directed against nuclear antigens. It is a multi-system disease, and patients can present in vastly different ways.
Anisur Rahman, Jessica J Manson
+11 more sources
Systemic Lupus Erythematosus [PDF]
Cell, 1996 Systemic Lupus Erythematosus (SLE) of childhood is a complex and challenging disease which can occur at any age. Identification of disease early in it's course and aggressive, appropriate management leads to improved outcome for an individual child. The history of SLE indicates how much progress has been made in the last quarter century.
Marisa S. Klein-Gitelman +1 more
openaire +6 more sources
Annals of the Rheumatic Diseases, 2022 Objectives To quantify global, regional and country-specific estimates of epidemiology of systemic lupus erythematosus (SLE). Methods Four databases were systematically searched, and a Bayesian hierarchical linear mixed model was constructed to estimate ...
Jingru Tian +4 more
semanticscholar +1 more source
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases, 2023 Objectives To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods An international Task Force formed the questions for the systematic literature reviews (January 2018–December ...
A. Fanouriakis +41 more
semanticscholar +1 more source
Brain Sciences, 2021 (1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies.
Alba Jerez-Lienas +9 more
doaj +1 more source
Arthritis & Rheumatology, 2022 To assess the efficacy and safety of deucravacitinib, an oral, selective, allosteric inhibitor of TYK2, in a phase II trial in adult patients with active systemic lupus erythematosus (SLE).
Eric F Morand +12 more
semanticscholar +1 more source